Gilead Sciences
Search results
Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives.
Sep 30, 2023 · Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
1 day ago · The initial public offering (IPO) of Emcure Pharmaceuticals Limited has attracted attention from investors, with the public issue being fully subscribed.. The total subscription for Emcure Pharma IPO stands at 4.98 times as of 5 PM. Qualified Institutional Buyers (QIB) category was subscribed at 1.00 times, Non-Institutional Investors (NII) at 13.67 times, retail investors have a subscription of 3.43 times, employees at 4.83 times.
2 days ago · The book running lead managers for the Emcure Pharma IPO are Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited. Link Intime India Private Ltd will serve as the registrar for the issue. About Emcure Pharmaceuticals. Emcure Pharmaceuticals, an Indian pharmaceutical company, develops pharmaceutical products across various major therapeutic areas.
3 days ago · Pune-based Emcure Pharmaceuticals has attracted significant interest from institutional investors, raising Rs 582.6 crore via an anchor book launched for a day on July 2. This fundraising was the...
2 days ago · Emcure Pharma's initial public offering is a mix of fresh issuance of shares worth Rs 800 crore, and an offer-for-sale (OFS) of 1.14 crore shares worth Rs 1,152.03 crore.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
2 days ago · Emcure Pharma IPO price band The IPO is priced in the range of Rs 960-1008 per share, where investors can bid for 14 shares in one lot. At the upper end, the company plans to raise Rs 1952 crore through the issue. Other details The company proposes to use the net proceeds from the fresh issue to be used towards payment of debt and for general corporate purposes.
Aug 5, 2021 · Emcure Pharmaceuticals, a leading pharmaceutical company engaged in developing, manufacturing & marketing a wide range of pharmaceutical products globally.
